Investigators and Program Directors

Select Publications

• Mohamed, H., Russo A.P., Szarowski D.H., McDonnell E., Lepak L.A, Spencer M.G., Martin D.L., Caggana M., and Turner J.N. Development and Characterization of On-chip Biopolymer Membranes, JOURNAL OF CHROMATOGRAPHY, (in press)
• Mohamed H., Russo A.P., Retterer S.T., Szarowski, D.H., Isaacson M., Turner J.N., Duva S., Caggana M. Cell Sorting of Rare Cells from Circulation, IEEE TRANSACTIONS IN NANOBIOSCIENCE, 3:251-256, 2004.
• Zhang, X., Caggana, M., Cutler, T. L., and Ding, X.: Development of a Real-time PCR-based Method for the Measurement of Relative Allelic Expression, and Identification of CYP2A13 Alleles with Decreased Expression in Human Lung. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPY, 311:373-381, 2004.
• Fitzgerald, T., Duva S., Pass K., Ostrer H., Oddoux C., Ruben R., Caggana M. The Frequency of GJB-2 and GJB-6 deletion mutations in the New York State Newborn Population: Feasibility of Genetic Screening for Hearing Deficits, CLINICAL GENETICS, 65:338-342, 2004.
• Zhang X., Chen Y., Liu Y., Ren X., Zhang Q-Y., Caggana M., and Ding X. Single Nucleotide Polymorphisms of the Human CYP2A13 Gene: Evidence for Null Allele, DRUG METABOLISM DISPOSITION, 31, 1081-1085, 2003.
• Crawford D.C., Caggana M., Harris K.B, Lorey F., Nash C., Pass K.A., Tempelis C., Olney R.S. Characterization of β-globin Haplotypes Using Blood Spots from a Population-Based Cohort of Newborns with Sickle Cell Disease, GENETICS IN MEDICINE, 4:328-335, 2002.
• Steinberg K.K., Beck J., Nickerson D., Hayes R., Gallagher M., Caggana M., Reid Y., Cosentino M., Ji J., Johnson D., Earley M., Lorey F., Hannon H., and Sampson E. DNA Banking for Epidemiologic Studies, EPIDEMIOLOGY, 13:246-254, 2002.

Contact Information

E-mail: caggana@wadsworth.org